Bausch + Lomb Technolas, a US-based eye care company, has obtained the CE mark for its Technolas Teneo 317 excimer laser workstation, which is designed to treat all types of ametropia (refractive errors).
In addition to traditional LASIK capabilities to treat myopia or nearsightedness, hyperopia or farsightedness and astigmatism, Teneo 317 has incorporated SUPRACOR, a corneal approach to treat presbyopia.
The Teneo 317 is the second femtosecond laser to be introduced by the company for supporting cataract and corneal procedures on a single platform.
Bausch + Lomb Technolas president Kristian Hohla said that new TENEO 317 features advanced ergonomics and incorporates next generation eyetracker technology.
"Furthermore, the TENEO 317 is a great addition to our product portfolio which includes our VICTUS femtosecond laser, which was the first femtosecond laser capable of supporting cataract and corneal procedures on a single platform," Hohla added.
With the enhanced ergonomic design and layout, the Teneo 317 offers patients a more comfortable and relaxing surgical experience.
